Tocqueville Asset Management’s AstraZeneca AZN Stock Holding History

Tocqueville Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,184	Closed	-$374K	–	655
2020 Q1	$374K	Buy	+4,184	New	+$394K	0.01%	501
2016 Q4	–	Sell	-4,679	Closed	-$308K	–	811
2016 Q3	$308K	Sell	4,679 -201	-4%	-$13.1K	﹤0.01%	708
2016 Q2	$295K	Buy	+4,880	New	+$283K	﹤0.01%	723
2014 Q3	–	Sell	-87	Closed	-$6K	–	895
2014 Q2	$6K	Buy	+87	New	+$6.29K	﹤0.01%	1582
2013 Q4	–	Sell	-5,724	Closed	-$297K	–	1355
2013 Q3	$297K	Buy	+5,724	New	+$287K	﹤0.01%	773

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Tocqueville Asset Management's AZN Position: Q2 2020 in Review

Tocqueville Asset Management sold out of AstraZeneca (AZN) in Q2 2020, closing a stake of 4,184 shares — an estimated $374K sold.

Tocqueville Asset Management first reported a position in AZN in Q3 2013 and held it in 5 quarters. The position peaked at $374K in Q1 2020. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

Tocqueville Asset Management reported no remaining AstraZeneca position as of Q2 2020 after selling out during the quarter.
Tocqueville Asset Management sold 4,184 AstraZeneca shares in Q2 2020, an estimated $374K.
Tocqueville Asset Management first reported a position in AstraZeneca in Q3 2013 and held it in 5 quarters.
Tocqueville Asset Management's AstraZeneca position peaked at $374K in Q1 2020.
669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on Tocqueville Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.